Plusoptix, Inc. is a leading company in the field of binocular photorefraction, offering vision technology for eye care professionals, schools, charities, and pediatricians. The company, founded in 2001, specializes in the manufacturing of the plusoptiX S09 and S12 Vision Screeners and A09 and A12 Pediatric Autorefractor. These innovative products, such as the binocular hand-held autorefractor/photoscreener, provide accurate and easy measurements of various eye parameters in less than one second, all from a comfortable 3.3 feet distance. This feature makes them especially effective for uncooperative children, simplifying the vision screening and initial examination process for babies, toddlers, and developmentally challenged patients. Plusoptix, Inc. operates within the manufacturing and medical devices industries, contributing to improved vision care processes. While specific details about their headquarters and recent investments are not available at the moment, the company's dedication to enhancing vision screening and examination processes solidifies its position as an attractive potential investment opportunity for venture capitalists. With a clear focus on addressing a critical aspect of healthcare, Plusoptix, Inc.'s innovative solutions and established position in the market make it an intriguing prospect for investors seeking to contribute to advancements in vision care technology. For more information, please visit their website here.
There is no investment information
No recent news or press coverage available for Plusoptix, Inc..